- Details
- Description
Packaging Size:
30 tablets per pack
Strength:
45 mg
Composition:
Ponatinib 45 mg
Treatment:
Certain types of Philadelphia chromosome-positive leukemia, including chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL), according to the applicable indication and physician's prescription.
Form:
Tablet
Brand:
PONADX
Quantity Unit:
Tablets
Manufacturer:
Lucius Pharma
PONADX 45 (Ponatinib) is a prescription medicine used as a targeted therapy for certain types of leukemia. Ponatinib is a tyrosine kinase inhibitor (TKI) that works by blocking abnormal proteins involved in the growth and survival of leukemia cells.
PONADX 45 is intended for oral use and may be used in appropriate patients with specific forms of Philadelphia chromosome-positive leukemia, according to the prescribing physician's instructions. Treatment should be carried out under appropriate medical supervision.
